Why Kenvue Stock Tumbled by 13% on Thursday
A potential legal headache for consumer healthcare giant Kenvue (NYSE: KVUE) was causing pain for investors on Thursday. Such troubles tend to spook the market; hence the more than 13% sell-off of Kenvue across that trading session. The S&P 500 (SNPINDEX: ^GSPC), by comparison, did much better on the day with "only" a 0.6% decrease. Until it was spun off into a separate company, Kenvue was part of sprawling pharmaceutical company Johnson & Johnson (NYSE: JNJ). The company has faced tens of thousands of lawsuits over its Johnson's Baby Powder, a once talc-based product that is widely alleged to have caused various types of cancer. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Quelle: MotleyFool
Nachrichten zu Kenvue
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Kenvue
Keine Analysen gefunden.